Ovarian Cancer Coverage from Every Angle
Editor:
Ursula A. Matulonis, MD
Advertisement
Advertisement

Recent News

Consequences of Restricting Hospital Choices for Ovarian Cancer Surgery
ALLOCATE Trial: Is Targeted Molecular Profiling Useful in Treating Ovarian Cancer?
Temozolomide Analog Under Study in Treatment of Ovarian Cancer
Olaparib Monotherapy for Ovarian Cancer Evaluated in SOLO3 Trial
Mirvetuximab Soravtansine Plus Bevacizumab in Platinum-Resistant Ovarian Cancer
ESHRE 2019: Assisted Reproductive Technology and Long-Term Risk of Ovarian Cancer
Addition of Adavosertib to Chemotherapy in Platinum-Resistant Ovarian Cancer
Paclitaxel Combination Therapies for Gynecologic Carcinosarcoma
Priority Review of Niraparib in Advanced Ovarian Cancer Granted by FDA
ASCO 2019: Dose-Ranging Study of IMGN853 With Gemcitabine in Ovarian Cancer
NCCN Research Collaboration in Advanced Ovarian Cancer
ASCO 2019: Adding Nintedanib to Neoadjuvant Chemotherapy in Ovarian Cancer
ASCO 2019: Niraparib Alone and in Combination Therapy for Platinum-Sensitive Ovarian Cancer
ASCO 2019: Effect of ACA on Early Diagnosis and Treatment of Ovarian Cancer
Metabolic Changes in Stroma May Promote Metastasis of Ovarian Cancer
High-Grade Serous Ovarian Cancer: Researchers Identify Potential Susceptibility Genes
FOXD3: Cellular Target Biomarker for Ovarian Cancer?
Ovarian Cancer’s Genetic Relationship to Other Cancers
Epithelial Ovarian Cancer: Clinical Relevance of Deregulation of Long Noncoding RNAs
Bioengineered Scaffolds: Another Step Toward Fertility Restoration?
Are Urine Biomarkers Ready for Prime Time in Detecting Early Ovarian Cancer?
Can Gene Fusions Alter Transcriptional Regulation in High-Grade Ovarian Cancer?
HOPA 2019: Intraperitoneal vs. Dose-Dense Chemotherapy in Stage III Ovarian Cancer
AACR 2019: Can Use of Oral Contraceptives Protect Against Aggressive Ovarian Cancer?
Rucaparib in Ovarian Cancer: Reversion Mutations in Predicting Treatment Resistance
SGO 2019: Dendritic Cell Vaccine Plus Chemotherapy in Ovarian Cancer
SGO 2019: Niraparib Maintenance and Quality of Life in Recurrent Ovarian Cancer
SGO 2019: Does Age Affect Efficacy of Rucaparib in Ovarian Cancer?
Role of Lymphadenectomy in Treating Ovarian Cancer
2019 ASCO-SITC Symposium: IL-12 Plasmid Plus Neoadjuvant Chemotherapy in Ovarian Cancer
Copyright © 2019 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.